{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acne+Rosacea&page=4", "query": { "condition": "Acne Rosacea", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 148, "total_pages": 15, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acne+Rosacea&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acne+Rosacea&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T00:49:54.429Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02576847", "title": "Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rosacea" ], "interventions": [ { "name": "Omiganan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Maruho Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 307, "start_date": "2015-10", "completion_date": "2018-02-08", "has_results": true, "last_update_posted_date": "2022-07-19", "last_synced_at": "2026-10-23T00:49:54.429Z", "location_count": 15, "location_summary": "Fremont, California • Miami, Florida • Miramar, Florida + 12 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miramar", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Arlington Heights", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02576847" }, { "nct_id": "NCT02028286", "title": "A 21 Day Pharmacokinetics Study in Papulopustular Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Papulopustular Rosacea" ], "interventions": [ { "name": "CLS001", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Maruho Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2014-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-04-14", "last_synced_at": "2026-10-23T00:49:54.429Z", "location_count": 2, "location_summary": "Hackensack, New Jersey • Austin, Texas", "locations": [ { "city": "Hackensack", "state": "New Jersey" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02028286" }, { "nct_id": "NCT02547441", "title": "Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rosacea" ], "interventions": [ { "name": "CLS001 (Omiganan)", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Maruho Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 463, "start_date": "2015-12", "completion_date": "2018-04-13", "has_results": true, "last_update_posted_date": "2022-08-02", "last_synced_at": "2026-10-23T00:49:54.429Z", "location_count": 13, "location_summary": "Fremont, California • Miami, Florida • Miramar, Florida + 10 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miramar", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Arlington Heights", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02547441" }, { "nct_id": "NCT01555463", "title": "Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Papulopustular Rosacea" ], "interventions": [ { "name": "Azelaic acid foam, 15% (BAY39-6251)", "type": "DRUG" }, { "name": "Vehicle foam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 961, "start_date": "2012-09", "completion_date": "2014-01", "has_results": true, "last_update_posted_date": "2023-06-09", "last_synced_at": "2026-10-23T00:49:54.429Z", "location_count": 49, "location_summary": "Birmingham, Alabama • Fremont, California • Los Angeles, California + 41 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Fremont", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01555463" }, { "nct_id": "NCT03263273", "title": "Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rosacea", "Papulopustular Rosacea" ], "interventions": [ { "name": "1% Topical Minocycline Gel", "type": "DRUG" }, { "name": "3% Topical Minocycline Gel", "type": "DRUG" }, { "name": "Topical Vehicle Gel", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Hovione Scientia Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 270, "start_date": "2017-10-30", "completion_date": "2019-07-01", "has_results": false, "last_update_posted_date": "2019-11-08", "last_synced_at": "2026-10-23T00:49:54.429Z", "location_count": 23, "location_summary": "Bryant, Arkansas • Rogers, Arkansas • Fremont, California + 17 more", "locations": [ { "city": "Bryant", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Fremont", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03263273" }, { "nct_id": "NCT01933464", "title": "An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Papulopustular Rosacea" ], "interventions": [ { "name": "Cromolyn Sodium", "type": "DRUG" }, { "name": "Normal Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 10, "start_date": "2013-08", "completion_date": "2014-04", "has_results": true, "last_update_posted_date": "2019-08-07", "last_synced_at": "2026-10-23T00:49:54.429Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01933464" }, { "nct_id": "NCT01631656", "title": "Combination Gel and Vascular ND in Mild to Moderate Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rosacea" ], "interventions": [ { "name": "Azelaic acid", "type": "DRUG" }, { "name": "Nd:Yag laser", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2010-07", "completion_date": "2011-02", "has_results": true, "last_update_posted_date": "2018-09-12", "last_synced_at": "2026-10-23T00:49:54.429Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01631656" }, { "nct_id": "NCT01186068", "title": "Dose Response Study of Patients With Erythematous Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Erythematous (Type One) Rosacea" ], "interventions": [ { "name": "V-101", "type": "DRUG" }, { "name": "vehicle", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Vicept Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 175, "start_date": "2010-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2010-11-24", "last_synced_at": "2026-10-23T00:49:54.429Z", "location_count": 7, "location_summary": "San Diego, California • Miami Beach, Florida • Louisville, Kentucky + 4 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Miami Beach", "state": "Florida" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Clinton Twp", "state": "Michigan" }, { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT01186068" }, { "nct_id": "NCT07443202", "title": "Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ocular Rosacea" ], "interventions": [ { "name": "lotilaner", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tarsus Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 155, "start_date": "2025-12-05", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-10-23T00:49:54.429Z", "location_count": 2, "location_summary": "Houston, Texas • Lynchburg, Virginia", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Lynchburg", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07443202" }, { "nct_id": "NCT02131636", "title": "Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Erythema", "Rosacea" ], "interventions": [ { "name": "AGN-199201", "type": "DRUG" }, { "name": "Vehicle to AGN-199201", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 440, "start_date": "2014-05", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2019-11-18", "last_synced_at": "2026-10-23T00:49:54.429Z", "location_count": 1, "location_summary": "Lynchburg, Virginia", "locations": [ { "city": "Lynchburg", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02131636" } ] }